doi: 10.1161/hc0102.101399
(Circulation. 2002;105:106.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
Adrenomedullin, an Endogenous Peptide, Counteracts Cardiovascular Damage
From the Department of Nephrology and Endocrinology, Faculty of Medicine (T.S., Y.S., K.A., T.F.), and the Institute of Molecular and Cellular Biosciences (S.K.), the University of Tokyo, Bunkyo-ku, Tokyo; Daiichi Pharmaceutical Co Ltd, Edogawaku, Tokyo (K.I.); the First Department of Internal Medicine, Miyazaki Medical College, Kiyotake, Miyazaki (K. Kitamura); and the National Cardiovascular Research Institute, Suita, Osaka (K. Kangawa), Japan.
Correspondence to Toshiro Fujita, MD, Department of Nephrology and Endocrinology, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku Tokyo, 113-8655, Japan. E-mailfujita-dis{at}h.u-tokyo.ac.jp
Background— Adrenomedullin (AM), a potent vasodilator peptide, is produced by posttranslational splicing of pro-adrenomedullin together with proadrenomedullin N-terminal 20 peptide (PAMP), another hypotensive peptide. Although both AM and PAMP have the potential not only to decrease blood pressure but also to protect organs from damage, there is no direct evidence for their individual physiological roles in vivo.
Methods and Results— Using knockout mice with the disruption of AM peptide alone, we investigated the organ-protective effect of AM. Although the AM-/- mutation in mice was embryonic lethal without any apparent phenotypic changes, AM+/- mice were viable and fertile; plasma and organ AM concentrations were almost half of those in AM+/+ mice. With the administration of angiotensin II (Ang II) on a high-salt diet for 12 days, marked perivascular fibrosis and intimal hyperplasia were found in coronary arteries of Ang II/salt–treated AM+/- mice, without the AM upregulation that was observed in Ang II/salt–treated AM+/+ mice. In AM+/- mice, Ang II/salt loading increased both urinary excretion of 8-hydroxydeoxyguanosine and isoprostane, markers of oxidative stress. Consistently, immunostaining of both p67phox and gp91phox, subunits of NAD(P)H oxidase and 3-nitrotyrosine, the metabolites of reactive oxygen species (ROS), and the generation of ROS measured by electron spin resonance spectroscopy apparently increased in the Ang II/salt–treated heart. These data suggested that the overproduction of oxidative stress might be involved in the cardiovascular changes induced by Ang II/salt loading.
Conclusions— The evidence presented supports the hypothesis that endogenous AM possesses a protective action against cardiovascular damage, possibly through the inhibition of oxidative stress production.
Key Words: peptides • angiotensin • genes • oxygen • stress
This article has been cited by other articles:
 |
|
 |
|
  A. P. Fernandez, J. Serrano, L. Tessarollo, F. Cuttitta, and A. Martinez Lack of adrenomedullin in the mouse brain results in behavioral changes, anxiety, and lower survival under stress conditions PNAS, August 26, 2008; 105(34): 12581 - 12586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Oba, M. Hino, and T. Fujita Adrenomedullin protects against oxidative stress-induced podocyte injury as an endogenous antioxidant Nephrol. Dial. Transplant., February 1, 2008; 23(2): 510 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nishida, T. Sato, M. Miyazaki, and H. Nakaya Infarct size limitation by adrenomedullin: protein kinase A but not PI3-kinase is linked to mitochondrial KCa channels Cardiovasc Res, January 15, 2008; 77(2): 398 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Fujita Insulin resistance and salt-sensitive hypertension in metabolic syndrome Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3102 - 3107. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Miksa, R. Wu, X. Cui, W. Dong, P. Das, H. H. Simms, T. S. Ravikumar, and P. Wang Vasoactive Hormone Adrenomedullin and Its Binding Protein: Anti-Inflammatory Effects by Up-Regulating Peroxisome Proliferator-Activated Receptor-{gamma} J. Immunol., November 1, 2007; 179(9): 6263 - 6272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sierro, C. Biben, L. Martinez-Munoz, M. Mellado, R. M. Ransohoff, M. Li, B. Woehl, H. Leung, J. Groom, M. Batten, et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 PNAS, September 11, 2007; 104(37): 14759 - 14764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Liu, T. Shimosawa, H. Matsui, F. Meng, S. C. Supowit, D. J. DiPette, K. Ando, and T. Fujita Adrenomedullin inhibits angiotensin II-induced oxidative stress via Csk-mediated inhibition of Src activity Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1714 - H1721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Harmancey, J.-M. Senard, P. Rouet, A. Pathak, and F. Smih Adrenomedullin Inhibits Adipogenesis Under Transcriptional Control of Insulin Diabetes, March 1, 2007; 56(3): 553 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Fujita The Renin System, Salt-Sensitivity and Metabolic Syndrome Journal of Renin-Angiotensin-Aldosterone System, September 1, 2006; 7(3): 181 - 183. [PDF]
|
|
|
|
 |
|
 M. Rahman, A. Nishiyama, P. Guo, Y. Nagai, G.-X. Zhang, Y. Fujisawa, Y.-Y. Fan, S. Kimura, N. Hosomi, K. Omori, et al. Effects of Adrenomedullin on Cardiac Oxidative Stress and Collagen Accumulation in Aldosterone-Dependent Malignant Hypertensive Rats J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1323 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ishikawa, T. Nishikimi, K. Akimoto, K. Ishimura, H. Ono, and H. Matsuoka Long-Term Administration of Rho-Kinase Inhibitor Ameliorates Renal Damage in Malignant Hypertensive Rats Hypertension, June 1, 2006; 47(6): 1075 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Miyashita, H. Itoh, H. Arai, T. Suganami, N. Sawada, Y. Fukunaga, M. Sone, K. Yamahara, T. Yurugi-Kobayashi, K. Park, et al. The Neuroprotective and Vasculo-Neuro-Regenerative Roles of Adrenomedullin in Ischemic Brain and Its Therapeutic Potential Endocrinology, April 1, 2006; 147(4): 1642 - 1653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Kim, J.-H. Yim, J.-H. Cho, J.-H. Kim, J.-H. Ko, S.-M. Kim, S. Park, and J.-H. Park Adrenomedullin Regulates Cellular Glutathione Content via Modulation of {gamma}-Glutamate-Cysteine Ligase Catalytic Subunit Expression Endocrinology, March 1, 2006; 147(3): 1357 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.W. Tam, K. Husmann, N.C. Clark, J.E. Clark, Z. Lazar, L.M. Ittner, J. Gotz, G. Douglas, A.D. Grant, D. Sugden, et al. Enhanced Vascular Responses to Adrenomedullin in Mice Overexpressing Receptor-Activity-Modifying Protein 2 Circ. Res., February 3, 2006; 98(2): 262 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nag, A. Kato, T. Nakada, K. Hoshijima, A. C. Mistry, Y. Takei, and S. Hirose Molecular and functional characterization of adrenomedullin receptors in pufferfish Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R467 - R478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kato, T. Tsuruda, T. Kita, K. Kitamura, and T. Eto Adrenomedullin: A Protective Factor for Blood Vessels Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2480 - 2487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Bowers, K. A. Katki, A. Rao, M. Koehler, P. Patel, A. Spiekerman, D. J. DiPette, and S. C. Supowit Role of Calcitonin Gene-Related Peptide in Hypertension-Induced Renal Damage Hypertension, July 1, 2005; 46(1): 51 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nagaya, H. Mori, S. Murakami, K. Kangawa, and S. Kitamura Adrenomedullin: angiogenesis and gene therapy Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1432 - R1437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fujita, T. Kuwaki, K. Ando, and T. Fujita Sympatho-Inhibitory Action of Endogenous Adrenomedullin Through Inhibition of Oxidative Stress in the Brain Hypertension, June 1, 2005; 45(6): 1165 - 1172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tsuruda, J. Kato, K. Hatakeyama, H. Masuyama, Y.-N. Cao, T. Imamura, K. Kitamura, Y. Asada, and T. Eto Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats Cardiovasc Res, March 1, 2005; 65(4): 921 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Supowit, A. Rao, M. C. Bowers, H. Zhao, G. Fink, B. Steficek, P. Patel, K. A. Katki, and D. J. DiPette Calcitonin Gene-Related Peptide Protects Against Hypertension-Induced Heart and Kidney Damage Hypertension, January 1, 2005; 45(1): 109 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. von der Hardt, M.A. Kandler, M. Chada, A. Cubra, E. Schoof, K. Amann, W. Rascher, and J. Dotsch Brief adrenomedullin inhalation leads to sustained reduction of pulmonary artery pressure Eur. Respir. J., October 1, 2004; 24(4): 615 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Ishikawa, K Hatakeyama, T Imamura, K Ito, S Hara, H Date, Y Shibata, Y Hikichi, Y Asada, and T Eto Increased adrenomedullin immunoreactivity and mRNA expression in coronary plaques obtained from patients with unstable angina Heart, October 1, 2004; 90(10): 1206 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Xing, T. Shimosawa, T. Ogihara, H. Matsui, K. Itakura, X. Qingyou, T. Asano, K. Ando, and T. Fujita Angiotensin II-Induced Insulin Resistance Is Enhanced in Adrenomedullin-Deficient Mice Endocrinology, August 1, 2004; 145(8): 3647 - 3651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nakamura, J. Kato, K. Kitamura, H. Onitsuka, T. Imamura, Y. Cao, K. Marutsuka, Y. Asada, K. Kangawa, and T. Eto Adrenomedullin Administration Immediately After Myocardial Infarction Ameliorates Progression of Heart Failure in Rats Circulation, July 27, 2004; 110(4): 426 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yoshimoto, N. Fukai, R. Sato, T. Sugiyama, N. Ozawa, M. Shichiri, and Y. Hirata Antioxidant Effect of Adrenomedullin on Angiotensin II-Induced Reactive Oxygen Species Generation in Vascular Smooth Muscle Cells Endocrinology, July 1, 2004; 145(7): 3331 - 3337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Matsui, T. Shimosawa, K. Itakura, X. Guanqun, K. Ando, and T. Fujita Adrenomedullin Can Protect Against Pulmonary Vascular Remodeling Induced by Hypoxia Circulation, May 11, 2004; 109(18): 2246 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Niu, T. Shindo, H. Iwata, S. Iimuro, N. Takeda, Y. Zhang, A. Ebihara, Y. Suematsu, K. Kangawa, Y. Hirata, et al. Protective Effects of Endogenous Adrenomedullin on Cardiac Hypertrophy, Fibrosis, and Renal Damage Circulation, April 13, 2004; 109(14): 1789 - 1794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kawai, K. Ando, A. Tojo, T. Shimosawa, K. Takahashi, M. L. Onozato, M. Yamasaki, T. Ogita, T. Nakaoka, and T. Fujita Endogenous Adrenomedullin Protects Against Vascular Response to Injury in Mice Circulation, March 9, 2004; 109(9): 1147 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nishikimi, F. Yoshihara, S. Horinaka, N. Kobayashi, Y. Mori, K. Tadokoro, K. Akimoto, N. Minamino, K. Kangawa, and H. Matsuoka Chronic Administration of Adrenomedullin Attenuates Transition From Left Ventricular Hypertrophy to Heart Failure in Rats Hypertension, November 1, 2003; 42(5): 1034 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Katsuki, Y. Sumida, H. Urakawa, E. C. Gabazza, N. Maruyama, K. Morioka, N. Kitagawa, Y. Hori, K. Nakatani, Y. Yano, et al. Increased Oxidative Stress Is Associated With Elevated Plasma Levels of Adrenomedullin in Hypertensive Patients With Type 2 Diabetes Diabetes Care, May 1, 2003; 26(5): 1642 - 1643. [Full Text] [PDF]
|
|
|
|
|
|
T. Shimosawa, T. Ogihara, H. Matsui, T. Asano, K. Ando, and T. Fujita Deficiency of Adrenomedullin Induces Insulin Resistance by Increasing Oxidative Stress Hypertension, May 1, 2003; 41(5): 1080 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yamasaki, J. Kawai, T. Nakaoka, T. Ogita, A. Tojo, and T. Fujita Adrenomedullin Overexpression to Inhibit Cuff-Induced Arterial Intimal Formation Hypertension, February 1, 2003; 41(2): 302 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M.C. Dixon A new altruist on the block: effects of adrenomedullin after myocardial infarction Cardiovasc Res, December 1, 2002; 56(3): 347 - 349. [Full Text] [PDF]
|
|
|
|
|
|
R. Nakamura, J. Kato, K. Kitamura, H. Onitsuka, T. Imamura, K. Marutsuka, Y. Asada, K. Kangawa, and T. Eto Beneficial effects of adrenomedullin on left ventricular remodeling after myocardial infarction in rats Cardiovasc Res, December 1, 2002; 56(3): 373 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tokudome, T. Horio, F. Yoshihara, S.-i. Suga, Y. Kawano, M. Kohno, and K. Kangawa Adrenomedullin Inhibits Doxorubicin-Induced Cultured Rat Cardiac Myocyte Apoptosis via a cAMP-Dependent Mechanism Endocrinology, September 1, 2002; 143(9): 3515 - 3521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Poyner, P. M. Sexton, I. Marshall, D. M. Smith, R. Quirion, W. Born, R. Muff, J. A. Fischer, and S. M. Foord International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors Pharmacol. Rev., June 1, 2002; 54(2): 233 - 246. [Abstract] [Full Text] [PDF]
|
|